Cardiology
Clinical
Epinephrine linked with more refractory cardiogenic shock after acute MI
Is there a difference in safety and efficacy when using epinephrine versus norepinephrine for cardiogenic shock after successful reperfusion in...
News
Poor response to statins hikes risk of cardiovascular events
Patients with better outcomes were more likely to have initiated therapy with a more potent drug.
Clinical
Statin exposure associated with idiopathic inflammatory myositis
What is the association between exposure to statin medications and histologically confirmed idiopathic inflammatory myositis?
News
PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan
NEW ORLEANS – “The early improvement in postdischarge outcomes supports the in-hospital initiation of sacubitril/valsartan.” – Dr. Adam D. DeVore...
HM19
Highlights from the ‘Updates in ACS’ session (VIDEO)
News
Clinicians, CMS confer over heart failure–readmission penalty
Latest News for HOSP
One-dose-fits-all aspirin administration strategy may not be advisable
Are the same doses of aspirin equally effective in preventing cardiovascular (CV) events and long-term colorectal risk reduction in patients of...
News
30-day readmissions after STEMI with cardiogenic shock 13%
WASHINGTON – Risk factors for 30-day readmission included female sex, older age, and comorbidities.
News
More chest compression–only CPR leads to increased survival rates
This alternative for bystanders raises both CPR performance rates and patient survival.
News
Ticagrelor reversal agent looks promising
NEW ORLEANS – Ticagrelor’s antiplatelet effect was squelched within 5 minutes.